Author:
Lang Kathleen,McGarry Lisa J.,Huang Huan,Dorer David,Kaufman Elise,Knopf Kevin
Subject
Cancer Research,Oncology,Hematology
Reference46 articles.
1. NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia;O'Brien;J Natl Compr Cancer Netw,2011
2. Treatment of chronic myeloid leukemia elderly patients in the tyrosine kinase inhibitor era;Russo;Curr Cancer Drug Targets,2013
3. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology, Chronic Myelogenous Leukemia, 2015, version 1. Available at http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed January 12, 2015.
4. A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia;Baccarani;Blood,2002
5. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group;Guilhot;N Engl J Med,1997
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献